Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 01 Mar 2023
Ophthalmological Clinical Trials Still Show Sociodemographic Disparities.
Read Full NewsPrograms offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.
Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.
A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.
1.
Childhood cancer survivors face new health problems later in life, study shows
2.
FDA Approves Subcutaneous Isatuximab for MM Indications
3.
Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer
4.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
5.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
1.
Integrated Techniques in Oncology in the Digital Era
2.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
3.
The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure
4.
From Autoimmune Disorders to COVID-19: How Plasmapheresis Is Revolutionizing Modern Medicine
5.
Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
3.
Thromboprophylaxis In Medical Settings- An Update
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge